会員登録
ログイン
【4438】Welby
疾患ソリューション事業・パーソナル・ヘルス・レコード事業・医療データ調査事業
類似企業：
【業界1位】
LINEヤフー
【業界1位】
LINEヤフー
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026.12 | 2026/08/13 | Q2予 | 1,466 | → | 0.0% | 0.0% | -30 | → | 0.0% | 0.0% | -30 | → | 0.0% | 0.0% | - | - | - | - |
| 2026.12 | 2026/05/15 | Q1予 | 1,466 | → | 0.0% | 0.0% | -30 | → | 0.0% | 0.0% | -30 | → | 0.0% | 0.0% | - | - | - | - |
| 2026.12 | 2026/02/24 | 当初予 | 1,466 | - | - | - | -30 | - | - | - | -30 | - | - | - | - | - | - | - |
| 2025.12 | 2026/02/13 | 実 | 635 | → | 0.0% | -44.9% | -452 | → | 0.0% | -425.6% | -454 | → | 0.0% | -427.9% | -539 | → | 0.0% | 0.0% |
| 2025.12 | 2026/01/30 | 修正予 | 635 | ↓ | -44.9% | -44.9% | -452 | ↓ | -425.6% | -425.6% | -454 | ↓ | -427.9% | -427.9% | -539 | - | - | - |
| 2025.12 | 2025/11/14 | Q3予 | 1,152 | → | 0.0% | 0.0% | -86 | → | 0.0% | 0.0% | -86 | → | 0.0% | 0.0% | - | - | - | - |
| 2025.12 | 2025/08/13 | 当初予 | 1,152 | - | - | - | -86 | - | - | - | -86 | - | - | - | - | - | - | - |
| 2024.12 | 2025/02/14 | 実 | 528 | → | 0.0% | -55.0% | -654 | → | 0.0% | -298.8% | -655 | → | 0.0% | -299.4% | -804 | → | 0.0% | 0.0% |
| 2024.12 | 2025/01/31 | 修正予 | 528 | ↓ | -55.0% | -55.0% | -654 | ↓ | -298.8% | -298.8% | -655 | ↓ | -299.4% | -299.4% | -804 | - | - | - |
| 2024.12 | 2024/11/14 | Q3予 | 1,173 | → | 0.0% | 0.0% | -164 | → | 0.0% | 0.0% | -164 | → | 0.0% | 0.0% | - | - | - | - |
| 2024.12 | 2024/08/13 | 当初予 | 1,173 | - | - | - | -164 | - | - | - | -164 | - | - | - | - | - | - | - |
| 2023.12 | 2024/02/14 | 実 | 575 | → | 0.0% | -50.3% | -437 | → | 0.0% | -312.3% | -438 | → | 0.0% | -313.2% | -505 | → | 0.0% | 0.0% |
| 2023.12 | 2024/01/31 | 修正予 | 575 | ↓ | -50.3% | -50.3% | -437 | ↓ | -312.3% | -312.3% | -438 | ↓ | -313.2% | -313.2% | -505 | - | - | - |
| 2023.12 | 2023/11/13 | Q3予 | 1,156 | → | 0.0% | 0.0% | -106 | → | 0.0% | 0.0% | -106 | → | 0.0% | 0.0% | - | - | - | - |
| 2023.12 | 2023/08/10 | 当初予 | 1,156 | - | - | - | -106 | - | - | - | -106 | - | - | - | - | - | - | - |
| 2022.12 | 2023/02/10 | 実 | 1,050 | - | - | - | 60 | - | - | - | 73 | - | - | - | 33 | - | - | - |
| 2021.12 | 2022/02/10 | 実 | 1,139 | - | - | - | -113 | - | - | - | -109 | - | - | - | -130 | - | - | - |
| 2020.12 | 2021/02/15 | 実 | 864 | → | 0.0% | -29.0% | -237 | → | 0.0% | -311.6% | -237 | → | 0.0% | -311.6% | -353 | → | 0.0% | -552.6% |
| 2020.12 | 2021/01/20 | 修正予 | 864 | ↓ | -29.0% | -29.0% | -237 | ↓ | -311.6% | -311.6% | -237 | ↓ | -311.6% | -311.6% | -353 | ↓ | -552.6% | -552.6% |
| 2020.12 | 2020/11/10 | Q3予 | 1,217 | → | 0.0% | 0.0% | 112 | → | 0.0% | 0.0% | 112 | → | 0.0% | 0.0% | 78 | → | 0.0% | 0.0% |
| 2020.12 | 2020/08/11 | Q2予 | 1,217 | → | 0.0% | 0.0% | 112 | → | 0.0% | 0.0% | 112 | → | 0.0% | 0.0% | 78 | → | 0.0% | 0.0% |
| 2020.12 | 2020/05/13 | Q1予 | 1,217 | → | 0.0% | 0.0% | 112 | → | 0.0% | 0.0% | 112 | → | 0.0% | 0.0% | 78 | → | 0.0% | 0.0% |
| 2020.12 | 2020/02/12 | 当初予 | 1,217 | - | - | - | 112 | - | - | - | 112 | - | - | - | 78 | - | - | - |
| 2019.12 | 2020/02/12 | 実 | 798 | → | 0.0% | -26.3% | 16 | → | 0.0% | -92.0% | -1 | → | 0.0% | -100.5% | -11 | ↓ | -1000.0% | -107.1% |
| 2019.12 | 2020/01/20 | 修正予 | 798 | ↓ | -26.3% | -26.3% | 16 | ↓ | -92.0% | -92.0% | -1 | ↓ | -100.5% | -100.5% | -1 | ↓ | -100.6% | -100.6% |
| 2019.12 | 2019/11/11 | Q3予 | 1,083 | → | 0.0% | 0.0% | 200 | → | 0.0% | 0.0% | 184 | → | 0.0% | 0.0% | 156 | → | 0.0% | 0.0% |
| 2019.12 | 2019/08/09 | Q2予 | 1,083 | → | 0.0% | 0.0% | 200 | → | 0.0% | 0.0% | 184 | → | 0.0% | 0.0% | 156 | → | 0.0% | 0.0% |
| 2019.12 | 2019/05/13 | 当初予 | 1,083 | - | - | - | 200 | - | - | - | 184 | - | - | - | 156 | - | - | - |
